Search Filters

Search Results

Found 22 results

510(k) Data Aggregation

    K Number
    K202813
    Date Cleared
    2021-06-14

    (263 days)

    Product Code
    Regulation Number
    876.4480
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Northgate Technologies Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Northgate Technologies Inc. AUTOLITH® URO-TOUCH 9 Fr Probe, bipolar disposable EHL is designed to be used with the Northgate Technologies Inc. AUTOLITH® URO-TOUCH unit/generator for the fragmentation of renal calculi located in the kidneys and urinary bladder.

    Device Description

    The Northgate Technologies Inc. AUTOLITH® URO-TOUCH 9 Fr Probe, bipolar disposable EHL is designed to be used with the Northgate Technologies Inc. AUTOLITH® URO-TOUCH unit/generator for the fragmentation of calculi located in the kidneys and urinary bladder.

    The Northgate Technologies Inc. AUTOLITH® URO-TOUCH System consists of a software controlled, electronic unit (Generator) which generates a single high-voltage pulse or a series of pulses across the tip of a flexible bipolar lithotripter probe. When discharged in 0.9% normal physiological saline solution, these pulses produce sharp, high-amplitude hydraulic shock waves that crack calculi (stones) located inside the body. They are capable of cracking calculi of virtually any size and composition. The objective is to reduce the size of the calculi so that fragments can be removed without major surgery.

    The AUTOLITH® URO-TOUCH System includes the following major components:
    AUTOLITH® URO-TOUCH Unit/Generator (K130368)
    Regulate the discharge voltage and repetition rate of a shot delivered to a connected extender cable and probe. Display the relative power delivered to the probe. Display the number of pulses to be delivered to the probe as requested by the operator. Automatically sense the existence of a plugged-in probe.
    Automatically preset start-up values for power and pulses according to the probe type.
    Automatically scale power range according to the probe type.
    Prohibit discharge of high voltage when the footswitch is activated if an extender cable/probe is not properly connected.
    Automatically compares the pulses delivered at the selected power levels and displays when to INSPECT or REPLACE PROBE.
    Displays the number of pulses delivered.
    Automatic AC Voltage Adjust. For use in all countries.

    The AUTOLITH® URO-TOUCH 9 Fr Probe is 54 cm long and is used with a transurethral scope for fragmentation of calculi in the kidneys and urinary bladder.

    The 9 Fr Probe, 54 cm long, was previously cleared by K914516 on January 7, 1992. The Extender Cable was cleared by K914517 on June 30, 1992.

    AI/ML Overview

    The provided document is an FDA 510(k) clearance letter for the Northgate Technologies Inc. AUTOLITH® URO-TOUCH 9 Fr Probe. This type of document primarily focuses on establishing substantial equivalence to a legally marketed predicate device, rather than providing extensive details about the performance of the device or a clinical study proving its effectiveness through specific acceptance criteria.

    The submission is for a design change to the device, specifically updating materials to comply with ISO 10993-1:2009 for biological safety. The document does not describe a study to prove the device meets acceptance criteria related to its clinical effectiveness or diagnostic performance (like an AI/ML device would). Therefore, many of the requested items (e.g., sample size for test set, number of experts for ground truth, MRMC study, standalone performance, training set details) are not applicable to this type of device clearance and the information provided in this document.

    However, I can extract the information that is present and explain why other information is absent based on the nature of this submission.


    Device: Northgate Technologies Inc. AUTOLITH® URO-TOUCH 9 Fr Probe
    Type of Submission: 510(k) Premarket Notification for a design change (material update for biological safety compliance). This is not an AI/ML device.

    Acceptance Criteria and Reported Device Performance (as inferred from the document for a materials update)

    Since this document is primarily about a material update for a medical device (Electro-Hydraulic Lithotriptor Probe) to comply with biological safety standards, the "acceptance criteria" and "reported device performance" are centered around the biocompatibility and functional equivalence tests, not clinical efficacy or diagnostic accuracy.

    Acceptance Criteria CategorySpecific Criteria (Inferred from Document)Reported Device Performance (Proof in Document)
    Material BiocompatibilityCompliance with ISO 10993-1:2009 for biological evaluation of medical devices."These materials have been tested and have passed the requirements of the ISO 10993-1 Standard. Listed below are the specific tests: Cytotoxicity, Sensitization, Irritation or Intracutaneous Reactivity, Acute Systemic Toxicity Test, Hemocompatibility, Latex-Free, DEHP Free." (Page 6)
    Functional EquivalenceThe updated probe must maintain the same intended use, indications for use, and physical characteristics (diameter, length, tip material) as the predicate device, and deliver comparable power output.- Intended Use & Indications for Use: "Fragmentation of cacti" (Intended Use) and "fragmentation of renal calculi located in the kidneys and urinary bladder" (Indications for Use) are substantially equivalent to the predicate, with a restriction on use in ureters for safety (Page 7, 8).
    • Physical Characteristics: Diameter (9 French), Length (54 cm), Tip Material (Brass) are identical to the predicate (Page 7).
    • Power Output: "Power output is discussed further in the Bench Testing section." (Page 7) - While not detailed, the implication in a 510(k) is that it's shown to be functionally equivalent for its purpose. |
      | Risk Assessment | New materials must not introduce new questions of safety or efficacy. | The risk assessment led to the removal of ureter indication due to risk of injury with the 9 Fr probe's power output (4000 PSI) (Page 8). This indicates a proactive risk mitigation. The conclusion states: "The different technological characteristics and information submitted to the FDA do not raise new questions of safety and efficacy and demonstrate that the device is at least as safe and effective as the legally marketed predicate device." (Page 8) |

    Information Not Applicable or Not Found in the Provided Document:

    The following information would typically be found in a submission for an AI/ML device or a device requiring a clinical efficacy study, but is not present or relevant for this specific 510(k) submission concerning a material update for an electro-hydraulic lithotripter probe.

    1. Sample sized used for the test set and the data provenance: Not applicable. The "test set" here refers to material testing for biocompatibility and bench testing for functional equivalence, not a clinical data set. There's no clinical "test set" described for performance evaluation in this document.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience): Not applicable. This relates to expert adjudication of clinical data, which is not part of this submission type. Ground truth for biocompatibility and functional tests is established by standardized laboratory methods.
    3. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable for the reasons above.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This is for AI/ML diagnostic devices.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. Not an algorithm/AI device.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not applicable for clinical ground truth. For material tests, ground truth is established by the specifications of the ISO standards and the results of the laboratory tests.
    7. The sample size for the training set: Not applicable. There is no AI/ML model or "training set" for this device.
    8. How the ground truth for the training set was established: Not applicable for the reasons above.

    In summary, this 510(k) pertains to a change in materials for an existing device to meet biological safety standards. The "study" referenced would be the battery of biocompatibility tests performed according to ISO 10993 standards and a comparison to the predicate device through bench testing, not a clinical trial or AI/ML performance evaluation.

    Ask a Question

    Ask a specific question about this device

    K Number
    K202944
    Date Cleared
    2021-03-25

    (176 days)

    Product Code
    Regulation Number
    878.5070
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Northgate Technologies Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    To remove airborne particles generated by tissue combustion during laparoscopic surgery, via filtration of gaseous media contained within the distended pneumoperitoneum in order to improve visualization. NEBULAE® SRS may be used in any laparoscopic surgery, as appropriate.

    Device Description

    This 510(k) submission for the NEBULAE® SRS Laparoscopic Surgical Smoke Removal System (henceforth referred to as NEBULAE® SRS) covers the following product codes:
    • NEBULAE® SRS Pump (7-700-00)
    • NEBULAE® SRS CO₂ Gas Filtration Tubing Sets (7-510-57)
    The NEBULAE® SRS is intended to recirculate CO2 gas in the pneumoperitoneum whilst removing surgical smoke during laparoscopic procedures. The system consists of two parts: a Pump and dedicated singleuse, sterile Tubing Sets.
    The NEBULAE® SRS Pump is a microprocessor driven, mains-powered device containing a DC motor. The single-use, disposable Tubing Set consists of an integrated cartridge, containing a diaphragm pump, an in-line ultra-low particulate air (ULPA) with activated carbon filter, fluid trap(s), 10 feet of DEHP-free PVC tubing and two connectors for connecting the tubing to the trocars. The NEBULAE® SRS Pump's DC motor drives the pump head in the Tubing Set's cartridge to create the flow of CO2 gas from the patient's pneumoperitoneum, through the fluid trap(s) and filter before re-entering the patient.
    The NEBULAE® SRS Pump can be positioned on a level surface (e.g. a surgical trolley in the operating room) or fixed to a vertical IV pole using a dedicated bracket, which is available as an accessory (See VOLUME 011 for further information).
    The re-circulating CO2 gas can also be warmed by the addition of an in-line gas warmer, also available as an optional accessory.

    AI/ML Overview

    The provided text describes the NEBULAE® SRS Laparoscopic Surgical Smoke Removal System. It primarily focuses on the device's design, intended use, and non-clinical testing to demonstrate its performance and substantial equivalence to a predicate device. This document is a 510(k) summary, which is a premarket notification to the FDA. As such, it details non-clinical testing, not necessarily clinical studies involving human performance or diagnostic accuracy.

    Therefore, many of the requested details, particularly those related to human-in-the-loop performance, ground truth establishment for a test set, expert consensus, and multi-reader multi-case studies, are not applicable or available in this document, as it concerns a physical medical device for smoke removal, not a diagnostic AI/CADe/CADx system.

    Here's a breakdown of the available information:

    1. Table of Acceptance Criteria and Reported Device Performance

    Test MethodologyPurposeAcceptance CriteriaResults
    Run the NEBULAE® SRS device for two hours, with the two tubing lines connected to flow meters, connected to two standard laparoscopic trocars, inserted into a laparoscopy simulation pressure chamber, insufflated with CO2 gas. Log the flow rate through each side of the Tubing Set.Design Verification, Software Validation - Functionality; Flow RateVerify that the device maintains a minimum flow rate of 10L/min, on each side of the disposable Tubing Set, throughout the two hours.Pass.
    Connect the two NEBULAE® SRS tubing lines connected to two standard laparoscopic trocars, and introduce various sources of occlusion to the flow. Test introducing the occlusion before and after starting the flow.Design Verification, Software Validation - Functionality; Occlusion DetectionVerify that the device detects each of the following sources of occlusion, stops flow, and produces an audiovisual alert: gas blocking moisture accumulations within the tubing line, closure of the trocar valve, obstruction of the trocar cannula, a kink in the tubing line, or a disconnected tubing line.Pass.
    Connect the in-line gas warmer to the device, and use a thermal camera to measure the temperature of the in-line gas warmer. Introduce each of the various fault conditions to the warmer.Design Verification, Software Validation— Functionality, Essential Performance; In-Line WarmerVerify that the in-line warmer reaches and maintains the set temperature. Verify that the user interface generates the designed audiovisual alert for each warmer fault condition.Pass.
    IEC 60601-1:2005, COR1:2006, COR2:2007, AMD1:2012 (or IEC 60601-1:2012 reprint)Electrical SafetyTest procedure: Informative. Standard test methods.Pass.
    IEC 60601-1-2:2014 (Emissions)Electrical Safety – Electromagnetic Compatibility; Emissions: General, Harmonic, FlickerClass A/ Group 1, IEC 61000-3-2:2014, IEC 61000-3-3:2013Pass.
    IEC 60601-1-2:2014 (Immunity)Electrical Safety – Electromagnetic Compatibility; Immunity: Electrostatic Discharge, Radiated Electromagnetic, Fast Transient, Surge, Conducted, Magnetic Field, Voltage Dips/ Interruptions/ Variations/fluctuationsIEC 61000-4-2, IEC 61000-4-3, IEC 61000-4-4, IEC 61000-4-5, IEC 61000-4-6, IEC 61000-4-8, IEC 61000-4-11Pass.
    ISO 10993-1:2018BiocompatibilityISO 10993-5:2009 /(R) 2014: Fluid Extract / L929 Mouse Fibroblast (Preliminary Assessment) and Fluid Extract / L929 Mouse Fibroblast; ISO 10993-10:2010 /(R)2014: Dermal Sensitization Guinea Pig Maximization (Cottonseed Oil and 0.9% NaCl) and Intracutaneous Test; ISO 10993-11:2017: Rabbit Pyrogen Test and Acute Systemic Toxicity TestPass.
    ISO 11137-1:2006, ISO 11137-2:2006Sterilization ValidationMicrobiological Validation of 25kGy Radiation Sterilization by ANSI/AAMI/ISO 11137-2 Method VDmax25Pass.
    ISO 11607-1: 2006, ISO 11607-2: 2006, ISTA 3A:2018, Dye Penetration Test, Seal Strength Test, Pull strength TestPackaging Integrity(Implicitly, to meet these standards)Pass.
    Condition the NEBULAE® SRS device per ISTA 3A:2018 and subsequently, per the shipping and storage environmental conditions of IEC 60601-1-11: 2015.Shipping and StorageVerify that the device still meets all the functional requirements that were previously verified in manufacturing (FQC).Pass.
    Qualitative assessment of users' ability to perform operational tasks and troubleshoot clinical use scenarios in a simulated environment.Validation- UsabilityGreater than 80% successful usability by subjects (clinicians)Pass.
    Qualitative evaluation of surgical environment visual clarity while running the NEBULAE® SRS, during monopolar and bipolar electrocautery and ultrasonic coagulation, in a simulated environment.Validation- Device Performance≤ 20% of subjects (surgeons) disagree that the NEBULAE® SRS helped maintain visual clarity by removing smoke and particulates from the field of vision.Pass.

    2. Sample Size Used for the Test Set and Data Provenance

    The document describes non-clinical performance and usability testing in simulated environments.

    • Performance/Functionality Tests: The sample size for device functionality tests (flow rate, occlusion detection, in-line warmer) is not explicitly stated as a number of distinct units tested, but the results indicate successful verification against stated criteria. These are engineering/device performance tests, not data sets for an algorithm.
    • Usability Study: The acceptance criteria mentions "subjects (clinicians)," implying human participants. The specific number of subjects is not provided.
    • Device Performance (Visual Clarity) Study: The acceptance criteria mentions "subjects (surgeons)," implying human participants. The specific number of subjects is not provided.
    • Data Provenance: The studies are described as "simulated environments" and "non-clinical testing." No information is provided regarding country of origin or whether it's retrospective or prospective, as these are device performance tests, not clinical data collection.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    This section is not applicable as the document describes a physical medical device for smoke removal, not a diagnostic AI/CADe/CADx system that would typically require expert-established ground truth for a test set. The "ground truth" for these tests is based on objective measurements of device performance, adherence to standards, and qualitative user feedback in simulated settings.

    For the "Usability" and "Device Performance" (visual clarity) qualitative assessments, the "ground truth" is based on the subjects' (clinicians/surgeons) direct experience and agreement/disagreement with the device's performance in the simulated environment. The number and qualifications of these subjects (clinicians/surgeons) are not specified beyond their professional titles.

    4. Adjudication Method for the Test Set

    This section is not applicable as the testing described focuses on device functionality and usability in simulated environments, not a diagnostic task requiring adjudication of expert opinions.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. This type of study is typically performed for diagnostic imaging devices or AI algorithms where human readers' performance is evaluated with and without AI assistance across multiple cases. The NEBULAE® SRS is a smoke removal system, not a diagnostic imaging device.

    6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

    This section is not applicable in the context of an AI algorithm. The device itself (NEBULAE® SRS pump and tubing set) has standalone performance characteristics (e.g., flow rate, occlusion detection, in-line warmer function) that were tested. These are device-specific functions, not an "algorithm" in the typical sense of AI/machine learning.

    7. The Type of Ground Truth Used

    The "ground truth" for the tests is derived from:

    • Objective device performance measurements: E.g., maintaining a minimum flow rate, correctly detecting occlusions, maintaining set temperature for the warmer.
    • Adherence to recognized industry standards: Such as IEC 60601 series for electrical safety and electromagnetic compatibility, ISO 10993 for biocompatibility, and ISO 11137 for sterilization.
    • Qualitative user feedback: For usability (successful task completion) and perceived visual clarity improvement by clinicians/surgeons in simulated settings.

    There is no "pathology" or "outcomes data" ground truth as this is a non-diagnostic device.

    8. The Sample Size for the Training Set

    This section is not applicable. The NEBULAE® SRS is a physical medical device. It is not an AI/machine learning algorithm that requires a "training set."

    9. How the Ground Truth for the Training Set Was Established

    This section is not applicable as there is no training set for an AI/machine learning algorithm.

    Ask a Question

    Ask a specific question about this device

    K Number
    K130368
    Date Cleared
    2013-11-15

    (274 days)

    Product Code
    Regulation Number
    876.4480
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The AUTOLITH® TOUCH unit is designed to be used with Northgate Technologies Inc. bipolar disposable EHL probes for the fragmentation of biliary calculi. The AUTOLITH® URO-TOUCH unit is designed to be used with Northgate Technologies Inc. bipolar disposable probes for the fragmentation of renal calculi.

    Device Description

    The AUTOLITH® TOUCH unit is designed to be used with Northgate Technologies Inc. bipolar disposable EHL probes for the fragmentation of biliary calculi. The AUTOLITH® URO-TOUCH unit is designed to be used with Northgate Technologies Inc. bipolar disposable probes for the fragmentation of renal calculi. Both devices operate just like the legacy (predicate) AUTOLITH® device. The units are softwarecontrolled, electronic devices capable of cracking calculi of virtually any size and composition. The devices are table-top units that connect to a disposable probe that is used in the working channel of an endoscope. A surgeon places the tip of the probe near the surface of the calculus/stone under endoscopic visualization. The physician then steps on a pneumatic foot pedal to activate the device. The electronic circuitry of the device generates a single high-voltage pulse or a series of pulses across the tip of the disposable flexible bipolar lithotripter probe. The discharge (in 0.9% normal physiological saline) produces sharp, high-amplitude hydraulic shockwaves that help to fragment the calculus/stone so it can be passed or removed without major surgery.

    AI/ML Overview

    The provided text describes a 510(k) summary for the AUTOLITH® TOUCH / AUTOLITH® URO-TOUCH lithotripters, stating their substantial equivalence to a predicate device. However, the document does not contain specific acceptance criteria, performance metrics, or details of a study proving the device meets acceptance criteria in the way typically expected for an AI/ML medical device submission.

    This document is for a medical device (lithotripter) that is not an AI/ML device, but rather a hardware device with software controls and slight modifications from its predecessor. Therefore, the questions related to AI/ML specific studies (like sample size for test/training sets, ground truth establishment, MRMC studies, standalone performance, etc.) are not applicable to this submission.

    The "Performance Data" section briefly mentions "Both Design Verification and Design Validation have been completed" and that "Non-clinical bench tests have been performed to prove substantial equivalence in the overall performance characteristics of the device."

    Here's an attempt to extract the relevant information based on the provided text, while acknowledging the limitations for AI/ML-specific questions:


    1. Table of Acceptance Criteria and Reported Device Performance

    The submission focuses on demonstrating substantial equivalence to a predicate device rather than meeting specific quantifiable performance acceptance criteria for a novel AI/ML algorithm. The core acceptance criterion for substantial equivalence in this context is that the new device produces the same pressure wave output as the current device.

    Acceptance Criteria (Implied)Reported Device Performance
    Production of the same pressure wave output as the predicate device"Comparison testing was performed to prove that the output of the Autolith Touch is, in fact, the same as the output of the current device. These tests compared both the voltage waveform output applied to the probe as well as the actual pressure wave output from the probe that will be applied to the target stone."

    The design goal was to produce a modern, simpler, and more reliable version of the current device while ensuring it "produces the same pressure wave output as the current AUTOLITH® device."

    "By design, the 6kV output capacitor is the main contributor in determining the voltage waveform applied to the probe. The new device incorporates the same 6kV output capacitor as the current device and uses modern circuitry to produce the same voltage waveform for the probe." |
    | Biological Safety | Materials used are "not toxic and have been previously used to manufacture other medical devices." Tests include: Cytotoxicity, Sensitization (Kligman Maximization), Irritation or Intracutaneous Reactivity, Acute Systemic Toxicity Test, Pyrogenicity, Latex, DEHP, all passing ISO 10993-1 requirements. |
    | Electrical and Functional Safety | The device functions as intended with features such as regulating discharge voltage, displaying power and pulse count, automatically sensing probes, preset start-up values, prohibiting discharge without proper connection, and displaying when to replace probes. The "Modifications have no impact on the application or efficacy of the accessories." |

    Study Details:

    The study referenced is the "Comparison testing" mentioned in the "Substantial Equivalence" section. This was a non-clinical bench test.

    2. Sample size used for the test set and the data provenance

    • Sample Size: Not specified for the bench testing. The testing would likely involve multiple iterations or samples of the device and various probes to ensure consistent output.
    • Data Provenance: Not applicable as it's a non-clinical bench test of physical output characteristics, not human or clinical data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • Not Applicable. This is a bench test comparing physical output characteristics (voltage waveform and pressure wave) to a predicate device. Ground truth is established by objective engineering measurements against the predicate device's known output, not expert human interpretation.

    4. Adjudication method for the test set

    • Not Applicable. See point 3.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • No. This is not an AI/ML device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    • Not Applicable. This is not an AI/ML device. While the device has software controls, its performance is measured by its physical output as a lithotripter, not an AI algorithm's diagnostic or predictive capabilities.

    7. The type of ground truth used

    • Objective measurement against predicate device's output. The "ground truth" was the voltage waveform output and pressure wave output of the already cleared predicate AUTOLITH® device. The new system was designed to replicate this physical output.

    8. The sample size for the training set

    • Not Applicable. This is not an AI/ML device, so there is no "training set" in the context of machine learning. The device was engineered to replicate the predicate's performance.

    9. How the ground truth for the training set was established

    • Not Applicable. See point 8.
    Ask a Question

    Ask a specific question about this device

    K Number
    K120151
    Device Name
    NEBULAE I
    Date Cleared
    2012-08-17

    (212 days)

    Product Code
    Regulation Number
    884.1730
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nebulae™ I 50 LPM Insufflator provides CO2 gas distention of surgical cavities for diagnostic and/or operative endoscopy. The insufflator has multiple operating modes which can be used for the following procedures: General Laparoscopic, Pediatric Laparoscopic, Bariatric Laparoscopic, Minimally Invasive Vessel Harvesting.

    Device Description

    The Nebulae™ I 50 LPM Insufflator is microprocessor controlled. This CO2 (Carbon Dioxide) High Flow Insufflator has touch screen control and multiple operating modes. The System can be used for General Laparoscopic, Pediatric Laparoscopic, Bariatric Laparoscopic, and Minimally Invasive Vessel Harvesting procedures.

    AI/ML Overview

    The Nebulae™ I 50 LPM Insufflator is a medical device designed to provide CO2 gas distention of surgical cavities for diagnostic and/or operative endoscopy. The acceptance criteria and the study proving the device meets these criteria are detailed below.

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Device Flow RatesBench testing in simulated use environment for all operating modes confirmed device performed within specified flow rates.
    Fill Time (Abdomen Simulator)Bench testing in simulated use environment proved the Nebulae™ I could fill an abdomen simulator within the specified time period.
    Flow AccuracyBench testing proved the Nebulae™ I could maintain specified flow accuracy for the flow rates in all modes, performing within the specified flow accuracy range.
    Overpressure ReliefBench testing proved the Nebulae™ I relieves overpressure conditions of 5mmHg above the preset and returns to the preset within the specified time range. Tested with different size abdominal simulators (to address all modes and sizes of pediatric patients) and at all specified flow rates, the device relieved pressure within the specified time. This also includes the functional requirement of "Relieves over pressure conditions of 5mmHg above the preset and returns to the preset in three (3) seconds or less."
    Comparative Flow Rate (vs. Predicate)The Nebulae™ I was tested along with predicate devices using an 11mm trocar with a 10mm laparoscope. Highest flow rates measured were 32 LPM. (Implies satisfactory comparative performance).
    Pediatric Mode Comparative TestingTested along with predicate device in pediatric mode (various weight modes, with Veress needle and trocar, appropriate simulated abdomen sizes). Response times to introduced/removed leaks and over/under pressure conditions were measured. Nebulae™ I performed as well as, or better than, the predicate device.
    Tissue Desiccation EffectCross-comparison test with 40L Abdominal Insufflator at maximum flow rates (5mm trocar, 5mm laparoscopic instrument, moist bovine liver, 30 and 60-second exposures). Results showed negligible change to tissue surface and no perceivable depth of desiccation. Concluded that 50LPM and 40LPM insufflators were identical relative to tissue desiccation and drying.
    Electrical Safety (IEC 60601-1:2005)Device shown to conform to standard.
    EMC (EN 60601-1-2:2007)Device shown to conform to standard.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the numerical sample sizes for each test (e.g., number of units tested, number of simulated abdomens, number of tissue samples). The testing appears to be solely bench testing in a simulated use environment; therefore, the data provenance is not from human subjects/patients, but rather from laboratory/bench testing, typically conducted in the country of manufacture (implied to be the USA, based on the applicant's address). The studies are prospective in nature, as they were conducted to evaluate the performance of the newly developed device.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not Applicable. The described studies are purely bench testing and do not involve human interpretation or subjective assessment of results by experts in a clinical context to establish ground truth. Performance was measured objectively against pre-defined specifications or through comparative measurements with predicate devices.

    4. Adjudication Method for the Test Set

    Not Applicable. As there are no human experts establishing ground truth or making subjective assessments requiring agreement, no adjudication method was used. The performance was determined by direct measurement and comparison with objective criteria.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

    No. A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not conducted as this device is a hardware insufflator and does not involve human readers interpreting images or data where AI assistance would be relevant.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    Yes. All reported performance testing was conducted as standalone bench testing, evaluating the algorithm's control of the device's mechanical and gas delivery functions without human intervention in the device's operational performance measurements. The "algorithm" in this context refers to the device's internal microprocessor control logic.

    7. The Type of Ground Truth Used

    The ground truth used for these studies consisted of:

    • Pre-defined engineering specifications/performance ranges: For criteria like flow rates, fill time, flow accuracy, and overpressure relief.
    • Objective measurements: Direct quantitative measurements obtained during bench testing.
    • Comparative performance against predicate devices: Performance of the Nebulae™ I was measured and directly compared to the performance of legally marketed predicate devices under similar conditions. This established an "equivalency ground truth" for certain aspects.
    • Standard conformity: Adherence to recognized electrical safety (IEC 60601-1:2005) and EMC (EN 60601-1-2:2007) standards.

    8. The Sample Size for the Training Set

    Not Applicable. This is a hardware medical device, and the submission describes verification and validation testing for a solidified design, not the iterative training of a machine learning algorithm. Therefore, there is no "training set" in the context of AI/ML development. The design, however, would have undergone extensive internal development and testing during its engineering phase, which could be considered analogous to "training" in a broad sense, but specific data sets for algorithm training are not relevant here.

    9. How the Ground Truth for the Training Set was Established

    Not Applicable. As explained above, there is no "training set" in the AI/ML context for this device. The underlying engineering principles and design parameters were established through conventional medical device design and development practices.

    Ask a Question

    Ask a specific question about this device

    K Number
    K041560
    Device Name
    FLO-ASSISTANT
    Date Cleared
    2004-09-28

    (110 days)

    Product Code
    Regulation Number
    884.1730
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nortech Flo-Assistant™ Product is indicated to provide a squeezing mechanism to a tubing set, providing increased capacity fluid irrigation for arthroscopic procedures.

    Device Description

    The Flo-Assistant™ is designed to be used with the Nortech® 7-510-33 Flo-Assistant™ tubing set for increased fluid capacity. The device is comprised of a main unit, cable and foot pedal assembly.

    AI/ML Overview

    I am sorry, but the provided text does not contain any information regarding acceptance criteria, device performance, or any studies conducted to prove the device meets specific criteria. The document is a 510(k) summary for the Flo-Assistant™ device, primarily focusing on its description, intended use, and assertion of substantial equivalence to predicate devices. It does not include details about clinical trials, performance specifications, or study methodologies.

    Ask a Question

    Ask a specific question about this device

    K Number
    K033614
    Date Cleared
    2004-07-29

    (255 days)

    Product Code
    Regulation Number
    884.1730
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The NORTECH IntraMyst Humidification System is indicated for use as a means of supplying humidity within the intra-abdominal cavity during diagnostic and/or operative laparoscopic procedures.

    Device Description

    Nortech's IntraMyst Humidification System incorporates front panel controls that are similar to Northgate's current Insufflators. The system is designed to provide continuous or on demand humidification to the laparoscopic environment. This may reduce the incidence of postoperative pain, diminish the likelihood of adhesion formation and reduce laparoscope lens fogging. The controller will contain the appropriate pneumatics for supplying and controlling the gas to the catheter at 100 PSI and 5 LPM. In addition, the controller will have displays for indicating abdominal pressure, overpressure, gas supply low, mist active, active pressure sense and amount of fluid dispensed.

    AI/ML Overview

    The Nortech IntraMyst Humidification System is a Class II device designed to provide continuous or on-demand humidification to the laparoscopic environment. The provided SSS document acts as a 510(k) premarket notification, which is a submission to the FDA to demonstrate that the device is substantially equivalent to legally marketed predicate devices. Therefore, the "acceptance criteria" and "device performance" in this context refer to the demonstration of substantial equivalence, rather than specific performance metrics from a dedicated clinical study for this device.

    Here's an analysis based on the provided document:

    1. A table of acceptance criteria and the reported device performance

    Acceptance Criteria (Demonstration of Substantial Equivalence)Reported Device Performance (as demonstrated by similarity to predicate devices)
    Intended Use: The device must have the same intended use as legally marketed predicate devices.The Nortech IntraMyst Humidification System is indicated for use as a means of supplying humidity within the intra-abdominal cavity during diagnostic and/or operative laparoscopic procedures. (This is stated to be substantially equivalent to predicate devices.)
    Technological Characteristics: The device must have technological characteristics (materials, design, operating principles) that are substantially equivalent to predicate devices.- Materials: Non-toxic and previously utilized in other devices.
    • Front Panel Controls: Similar to Northgate's current insufflators.
    • Controller Functionality: Contains appropriate pneumatics for gas supply and control (100 PSI, 5 LPM), with displays for abdominal pressure, overpressure, gas supply low, mist active, active pressure sense, and fluid dispensed.
    • Standards Compliance: Will meet UL-2601-1, CAN/CSA-C22.2 No. 601.1, EN 60601-1, EN 60601-1-2. Microbiological testing to meet ISO 10993-X. |
      | Safety and Effectiveness: When compared to predicate devices, the new device must not raise different questions of safety and effectiveness. | The document implicitly asserts this by claiming "substantial equivalence in materials, and intended use to numerous currently marketed devices." The compliance with recognized standards (UL, CAN/CSA, EN, ISO) suggests the device's safety and effectiveness will be comparable. |

    2. Sample size used for the test set and the data provenance

    The document does not describe a clinical "test set" in the traditional sense for evaluating device performance against pre-defined criteria. This is a 510(k) submission focused on substantial equivalence, which primarily relies on direct comparison to predicate devices, engineering testing (to meet standards), and possibly bench testing. Therefore:

    • Sample Size for Test Set: Not applicable in the context of a clinical performance study. The evaluation likely involved engineering tests and potentially bench tests, but no specific human clinical test set is described.
    • Data Provenance: Not applicable in the context of a clinical performance study. The information provided is about the device's design, materials, intended use, and its assertion of substantial equivalence to predicate devices, rather than clinical data from a new study.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. As this is a 510(k) submission focusing on substantial equivalence, there is no mention of a human-in-the-loop clinical test set requiring expert consensus for ground truth.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. No clinical test set requiring adjudication is described.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This device is a laparoscopic insufflator and humidification system, not an AI-based diagnostic or assistive technology for human readers.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a medical device, not an algorithm. Its performance would be evaluated through engineering specifications, bench testing, and compliance with standards, not as a standalone algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    Not applicable. For a 510(k) submission of this type of device, "ground truth" isn't typically established in the sense of clinical outcomes or expert labels. Instead, the "ground truth" is that the predicate devices are legally marketed and considered safe and effective, and the new device demonstrates equivalence to them through design, materials, and intended use. Performance is implicitly demonstrated by meeting recognized safety and performance standards.

    8. The sample size for the training set

    Not applicable. This device is not an AI/ML product developed using a training set.

    9. How the ground truth for the training set was established

    Not applicable. This device is not an AI/ML product developed using a training set.

    Ask a Question

    Ask a specific question about this device

    K Number
    K022052
    Date Cleared
    2003-01-24

    (214 days)

    Product Code
    Regulation Number
    884.1730
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The NORTECH 40LPM ABDOMINAL INSUFFLATOR®, 72-00203-0 SHALL BE USED FOR GAS DISTENTION OF THE ABDOMEN FOR DIAGNOSTIC AND/OR OPERATIVE LAPAROSCOPY.

    Device Description

    The Abdominal CO, Gas Insufflator (catalog # 72-00203-0) incorporates front panel controls similar to our current Omniflator® model #7640, although it utilizes membrane switches. The Abdominal Insufflator has an adjustable gas flow rate from 0-40 LPM. The unit shall have direct patient pressure monitoring which can be used by attaching the direct patient monitoring tubing set to the Omniflator® patient monitoring connector and subsequently into a cannula or trocar after initial insufflation has been achieved. The user has an option to utilize CO2 from a central supply or E-Cylinder tank.

    AI/ML Overview

    This document is a 510(k) premarket notification for a laparoscopic insufflator. It describes the device, its intended use, and states that it is substantially equivalent to legally marketed predicate devices.

    The document does not contain acceptance criteria for device performance or a study demonstrating that these criteria are met. This type of information is typically found in design verification and validation reports, which are part of the technical documentation submitted to the FDA but are not usually included in the public-facing 510(k) summary or cover letters.

    Therefore, I cannot provide the requested information based solely on the provided text. The prompt asks for information that is not available in these specific parts of the 510(k) submission.

    To answer your questions, I would need access to the actual performance and testing data, which are not present in the provided excerpt. The document only states that the device is substantially equivalent, implying that its performance is comparable to existing predicate devices, but it does not quantify this performance or detail specific tests.

    Ask a Question

    Ask a specific question about this device

    K Number
    K010053
    Date Cleared
    2001-10-23

    (288 days)

    Product Code
    Regulation Number
    884.1730
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    K Number
    K011928
    Date Cleared
    2001-08-10

    (51 days)

    Product Code
    Regulation Number
    880.5440
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    THE HYDROTOWER® ARTHROSCOPIC ADMINISTRATION TUBING SET IS USED TO MOVE FLUID FROM THE TOWER BAG TO THE PATIENT.

    Device Description

    The Hydrotower® Arthroscopic Administration Tubing Set is designed to be used with the Nortech® Hydrotower® System. The device is comprised of pvc tubing, check valve, a pressure relief valve, and numerous polymer fittings.

    AI/ML Overview

    The provided text does not contain information about the acceptance criteria or a study proving that the device meets those criteria. The document is a 510(k) summary for the Hydrotower® Arthroscopic Administration Tubing Set, which primarily focuses on establishing substantial equivalence to a predicate device.

    Therefore, I cannot provide the requested table or answer the questions related to the study design, sample sizes, expert qualifications, or comparative effectiveness.

    Ask a Question

    Ask a specific question about this device

    K Number
    K001325
    Date Cleared
    2000-08-18

    (114 days)

    Product Code
    Regulation Number
    876.5130
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    NORTHGATE TECHNOLOGIES, INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    Device Description
    AI/ML Overview
    Ask a Question

    Ask a specific question about this device

    Page 1 of 3